Theme: Advancing the Future of Regenerative Medicine through Scientific Innovation, Scalable Manufacturing, and Global Access​

The 2nd Edition of Cell & Gene Therapy Conference (CGTWC 2026) brings together global leaders from biotech, pharma, academia, physicians, investment firms, and regulatory agencies to accelerate the development, manufacturing, and commercialization of advanced cell and gene therapies (CGTs).

This event serves as a high-impact platform for clinical development, translational breakthroughs, scalable bioprocessing solutions, and strategic market growth discussions that define the future of cell and gene therapies. Our program is designed to go beyond scientific discovery, focusing on the practical, preclinical & clinical research, operational, regulatory, and commercial pathways required to bring transformative therapies to patients worldwide.

Conference Vision and Mission:

Empowering the global cell and gene therapy ecosystem by advancing scientific breakthroughs into clinically accessible, commercially scalable, and equitably available therapies that improve patient outcomes and transform the healthcare future. Our mission is to:

• Unite leading scientific experts with pharmaceutical and biotechnology innovators to accelerate therapeutic progress.
• Provide a high-visibility platform for cell and gene therapy startups to showcase research, technologies, and translational potential.
• Accelerate the development, manufacturing, and delivery of cell and gene-based therapies from research to real-world clinical use.
• Advance pricing, reimbursement, and global access strategies to make transformative therapies economically viable and widely available.
• Foster impactful collaborations between Pharma, Biotech, CMOs, and CDMOs to enable efficient scale-up, manufacturing excellence, and commercial readiness.

Conference Highlights - 2nd Edition of Cell & Gene Therapy Conference 2026 (CGTWC):​

• Thematic Focus: Exploring ethics, efficacy, and societal impacts of cell and gene therapies.
• Keynote Sessions: Insights from researchers, clinicians, industry executives, and policymakers.
• Scientific Tracks: Gene editing and cellular engineering technologies, Clinical translation, and Regulatory and safety frameworks.
• Hands-On Workshops: Practical training on manufacturing, delivery systems, and editing techniques.
• Industry and Startup Showcase: Platform for biotech innovators, platform technology developers, and emerging startups to showcase their research findings.
• Strategic Panel Discussions: Expert-driven dialogues on accessibility, pricing & reimbursement models, and personalized medicine.
• Networking and Partnering Opportunities: Connect with experts, collaborators, and investors.
• Policy and Access Focus: Discussions on equitable access and sustainable development.
• Miami Location: Leverage the city’s world-class biotech ecosystem.
• Future-Oriented Agenda: Insights on emerging technologies, scalability, and global health strategies.

Who Should Attend CGTWC 2026?

• Biotech and Pharma Executives
• CMC & Biomanufacturing Leaders
• Clinicians and healthcare providers
• Technology & Platform Innovators
• Investors, Accelerators & Venture Funds
• Regulatory bodies and policymakers.
• Bioethics experts
• Legal professionals
• Students or early-career professionals
• Patient advocacy groups and non-profit organizations

At CGTWC 2026, you will have the opportunity to connect with leaders from academia, industry, healthcare, policy, and patient advocacy. Whether you are building partnerships, exchanging ideas, or learning from experts, this environment enables meaningful collaboration that advances both professional growth and global healthcare impact.